GlobeNewswire by notified

IBFD Academic Chairman, Pasquale Pistone, appointed Hauser Global Faculty (NYU School of Law) Visiting Professor

Share

AMSTERDAM, Jan. 09, 2023 (GLOBE NEWSWIRE) -- We are delighted to announce that, as of January 2023, top academic expert Prof. Dr Pasquale Pistone has been appointed as Visiting Global Professor of Law at Hauser Global Faculty (NYU School of Law).

As part of this prestigious appointment, Prof. Pistone will be a lecturer on Tax Treaties and Comparative Tax Policy Seminar courses, helping this leading institution enhance its academic programmes.  

During the Spring Semester 2023, Prof. Pistone will be based in New York City in the United States, and he will be conducting research on the reform of international tax nexus in the framework of the works of the Tax Committee of the International Law Association.

“IBFD is extremely proud of its Academic Chairman, a true global ambassador and our strong linking pin with the academic world. We are very pleased that the Hauser Global Faculty has chosen to honour Prof. Pistone and we look forward to a fruitful relationship with this great university,” said IBFD CEO, Jan Maarten Slagter.

About Prof. Pistone
Prof. Pistone is the Academic Chairman of IBFD. He holds a Jean Monnet ad personam Chair in European Tax Law and Policy at WU Vienna University of Economics and Business (Austria) and is Full Professor of Tax Law at the University of Salerno (Italy).

His main fields of expertise are European and international tax law, in which he is regarded as a top academic expert throughout the world.

Contact information: Phil Windus, Senior Marketing Coordinator: p.windus@ibfd.org.

IBFD Academic
IBFD encourages academic excellence. It is our mission to stimulate the development of cross-border taxation and ensure the widest dissemination of tax knowledge. Our academic portfolio is key to achieving this goal. As the world’s leading think tank in international tax law, we engage in an extensive range of academic activities. We work closely with universities and scientific institutions around the world to advance expertise and excellence throughout the international tax community

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/63dd1ef5-f3a4-4d45-9e6a-2127445e5203

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Havila Kystruten AS: Havila Pollux Cancels Upcoming Round Trip8.5.2024 23:15:38 CEST | Press release

Havila Pollux has been docked in Bergen since May 2nd for planned warranty work, after an electro motor supplying power to the propulsion system had to be replaced. In recent days, testing of the new electro motor has been conducted, during which a malfunction was discovered in a bearing in the underwater housing of one of the propellers (azimuth POD). Sailing the ship in service with this malfunction is not deemed safe, and the newly discovered issue must be rectified. Consequently, Havila Pollux will sail to GMC in Stavanger to be placed in dry-dock for the replacement of the propeller's underwater housing. This replacement is also considered warranty work. As a result, the upcoming round trip departing from Bergen on May 13th will be cancelled. Considering the necessary preparations by the Norwegian equipment supplier and the replacement of the underwater housing, it is expected that Havila Pollux will resume its regular service from Bergen no later than May 24th. All affected passe

Havila Kystruten AS: Havila Pollux kansellerer kommende rundtur8.5.2024 23:15:38 CEST | Pressemelding

Havila Pollux har siden 2. mai ligget til kai i Bergen for planlagte garantiarbeider, etter at en elektromotor som forsyner propellsystemet med kraft måtte byttes ut. De siste dagene har det vært utført testing av den nye elektromotoren, og i forbindelse med det er det oppdaget en feil på et lager i undervannshuset til den ene propellen (azimut POD). Å seile skipet i rute med denne feilen er ikke sikkerhetsmessig forsvarlig, og den nyoppdagede feilen må utbedres. Havila Pollux vil derfor seile til GMC i Stavanger for å settes i tørrdokk for bytte av undervannshuset til propellen. Denne utskiftingen anses også som garantiarbeid. Den kommende rundturen med avgang fra Bergen 13. mai vil derfor kanselleres. Hensyntatt nødvendige forberedelser fra den norske utstyrsleverandøren samt utskiftning av undervannshuset, er det er forventet at Havila Pollux er tilbake i rute igjen fra Bergen senest 24. mai. Alle berørte passasjerer blir kontaktet av Havila Kystruten. Kontakter: Administrerende dir

Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update8.5.2024 22:15:38 CEST | Press release

Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trial Zeno BLA accepted for priority review by the FDA for the treatment of NRG1+ NSCLC and PDACBased on the Company’s current operating plan, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations into 2027 UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the first quarter and provided a business update. “At the upcoming 2024 ASCO meeting, we are looking forward to presenting multiple datasets including the first clinical data on safety and efficacy of petosemtamab in combination with pembrolizumab in previously untreated head and neck cancer. With p

CrossAmerica Partners LP Reports First Quarter 2024 Results8.5.2024 22:15:00 CEST | Press release

Allentown, PA, May 08, 2024 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports First Quarter 2024 Results Reported First Quarter 2024 Net Loss of $17.5 million that includes a $15.9 million loss on lease terminations with Applegreen, Adjusted EBITDA of $23.6 million and Distributable Cash Flow of $11.7 million compared to a Net Loss of $1.0 million, Adjusted EBITDA of $31.7 million and Distributable Cash Flow of $19.1 million for the First Quarter 2023Reported First Quarter 2024 Gross Profit for the Wholesale Segment of $27.0 million compared to $31.2 million of Gross Profit for the First Quarter 2023 and First Quarter 2024 Gross Profit for the Retail Segment of $54.4 million compared to $50.8 million of Gross Profit for the First Quarter 2023Leverage, as defined in the CAPL Credit Facility, was 4.49 times as of March 31, 2024, compared to 4.21 times as of December 31, 2023The Distribution Coverage Ratio for the trailing twelve months ended March 31, 2024 was 1.37 times compared to 1

HiddenA line styled icon from Orion Icon Library.Eye